Vir Biotechnology (VIR) EBT Margin Growth (1y) (2019 - 2026)
Powered by 
Analysis
Vir Biotechnology (VIR) EBT Margin Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 553.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 4,709.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1,076.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1,911.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -392.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,565.00 |
| 10 | Vir Biotechnology | 1.92 Bn | 1.92 Bn | 238.95 Mn | 915,945.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 915,945.00 |
| Mar 31, 2026 | -42.89 Mn |
| Dec 31, 2025 | 77,872.00 |
| Sep 30, 2025 | -5.89 Mn |
| Jun 30, 2025 | -457,660.00 |
| Mar 31, 2025 | -387,379.00 |
| Dec 31, 2024 | -12,658.00 |
| Sep 30, 2024 | -265,829.00 |
| Jun 30, 2024 | 65,545.00 |
| Mar 31, 2024 | 11,214.00 |
| Dec 31, 2023 | -41,245.00 |
| Sep 30, 2023 | -637,211.00 |
| Jun 30, 2023 | -462,946.00 |
| Mar 31, 2023 | -30,224.00 |
| Dec 31, 2022 | -37,406.00 |
| Sep 30, 2022 | -4,877.00 |
| Jun 30, 2022 | -61,020.00 |
| Mar 31, 2022 | 861,301.00 |
| Dec 31, 2021 | 680,102.00 |
| Sep 30, 2021 | 449,419.00 |